A new sarcoma clinical trial bridges adolescent and adult care at the MUHC
Highlighting the MUHC’s unique ability to bridge pediatric and adult cancer care, the trial evaluates a new...
MUHC launches world’s first radioligand therapy trial for HER2-positive cancers
The MUHC is the first site in the world to launch a first-in-human Phase I clinical trial evaluating a novel radioligand...
Nine Institute Labs Earn Highest Rating in My Green Lab Certification
A landmark sustainability milestone for The Institute’s research community
From the lab to the clinic: Spring Research Days showcase The Institute’s scientific momentum
Spring 2026 events united researchers, clinicians and trainees across disciplines to push the boundaries of discovery...
The MUHC and The Institute launch the IMPACT Centre to accelerate healthcare innovation and generate economic benefits for Quebec
A coordinated pathway for researchers, clinicians and industry partners to...
FRQ competition: More than $2.5M for research teams at The Institute
These salary awards support research programs spanning cancer, infectious diseases, child health, neurology and many other fields.
Canada’s Best: an ambitious postdoctoral fellowship program powered by philanthropy
Thanks to the generous support of the MUHC’s affiliated foundations, The Institute launches a competitive...
From vision to impact: Transforming clinical trials at The Institute
Under the 2030 Vision, Research Priority 4 is accelerating investigator-led, innovative and inclusive clinical trials — strengthening The Institute’s role...
Sustaining Excellence competition supports top-ranked researchers
Outstanding CIHR applicants maintain research momentum thanks to funding support from generous donors
Ten McGill research projects receive $42 million from CFI Innovation Fund
Investment supports research infrastructure including biofabrication project led by The Institute’s Darcy...